NATCO Pharma announced that its fully owned Canadian subsidiary, NATCO Pharma (Canada) Inc., has invested US$ 8 million in eGenesis, Inc., a biotechnology firm specializing in xenotransplantation and dedicated to developing safe and effective human-compatible organs for transplantation.
Comments
Post a Comment